Aptar Pharma and Mass General Partner on Predictive Nose-to-Brain Drug Delivery Platform
AptarGroup and MGH’s Alice Stanton Launch Research Collaboration to Advance Nose-to-Brain Drug Delivery AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies and consumer product…
Guardant Health’s Shield Test Gains EviCore Coverage for Colorectal Cancer Screening
Guardant Health’s Shield Blood Test Gains EviCore Coverage, Expanding Access to Colorectal Cancer Screening Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that its Shield™ blood test…
Paradromics Achieves Real-Time Speech with Connexus Brain-Computer Interface
Paradromics Connexus BCI Enables First Participant to Communicate in Real Time Using Neural Signals Paradromics Inc., a neurotechnology company developing a high-data-rate brain-computer interface (BCI) platform aimed at restoring and…
AESARA Appoints Denise Sánchez as VP of Regulatory Counsel and Compliance
AESARA Appoints Denise Sánchez as Vice President of Regulatory Counsel & Compliance Strategies AESARA, a leading Value & Access agency, has announced the appointment of Denise Sánchez, JD, MS, MA,…
Vyriad Begins Phase 1 Trial of In Vivo CAR T Therapy VV169
Vyriad Receives FDA Clearance to Begin Phase 1 Trial of VV169 In Vivo CAR T Therapy for Multiple Myeloma Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies for…
Lightcast Names Sarah Taylor Vice President of Science
Lightcast Appoints Sarah Taylor, PhD, as Vice President of Science to Advance Envisia Single-Cell Analysis Platform Lightcast, a life science tools company focused on functional single-cell analysis, has appointed Sarah…
Retension Pharmaceuticals Forms Scientific Advisory Board
Retension Pharmaceuticals Forms Scientific Advisory Board to Support RTN-001 Phase 2b Hypertension Development Retension Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing medicines for hypertension and other cardiovascular diseases,…
SonoThera Names Dr. Adam J. Shaywitz Chief Medical Officer
SonoThera Appoints Adam J. Shaywitz, M.D., Ph.D., as Chief Medical Officer to Advance Genetic Medicine Pipeline SonoThera, a biotechnology company developing next-generation genetic medicines designed to address the underlying causes…
Vyome Appoints Jerry Leonard as Chief Financial Officer
Vyome Holdings Appoints Jerry Leonard as Chief Financial Officer to Strengthen Financial Operations and Support Pipeline Development Vyome Holdings, Inc. (Nasdaq: HIND), a clinical-stage biopharmaceutical company developing differentiated therapies for…
Family Heart Foundation Study Highlights FIND Model for Targeted Lp(a) Screening
Family Heart Foundation Study Shows Machine Learning Model Can Help Identify ASCVD Patients at Higher Risk of Elevated Lp(a) The Family Heart Foundation, a leading research, education and advocacy organization…
NImmune Biopharma Presents Positive NIM-1324 IBD Data at ACG 2026
NImmune Biopharma to Present Clinical and Preclinical Data on NIM-1324 at ACG 2026, Highlighting LANCL2 Potential in Difficult-to-Treat IBD NImmune Biopharma, a private, late-stage precision inflammation and immunology (I&I) biopharmaceutical…
Quanterix Appoints Dr. Yuri Fesko as Chief Medical Officer
Quanterix Appoints Dr. Yuri Fesko as Chief Medical Officer to Advance Diagnostics Strategy Quanterix Corporation, a global leader in precision biomarker science, has announced the appointment of physician executive Dr.…